Incyte Corporation (INCY) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 22.85B USD. 52-week range 82.82 to 132.60 USD. Trailing P/E 14.4. Data as of 2026-10-09.
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI for the treatment of myelofibrosis (MF), polycythemia vera, and steroid-refractory acute graft-versus-host disease; ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; MONJUVI/ MINJUVI for the treatment of diffuse large ...